Approximately 70% of all GC cases are characterised by TP53 mutations,71 whereas TP53 mutations in EBVaGC are instead rare, with a mutation rate of only 15.1%.58,72,73 The distinct characteristic that EBVaGC mostly expresses, wild-type p53, can be exploited in several ways. Here, TP53 is linked to gastric cancer.